60 Degrees Pharmaceuticals is a leading company based in Washington, DC, dedicated to the development and commercialization of innovative medicines for the treatment and prevention of infectious diseases. With a mission to create vital medicines that can significantly improve and extend people's lives, they are focused on addressing critical research gaps and finding new ways to target infectious diseases, including COVID-19, malaria, babesiosis, fungal diseases, and dengue fever.
Since its establishment in 2010, 60 Degrees Pharmaceuticals has been at the forefront of applying scientific advancements to develop new therapies and disrupt the lifecycle of parasites. Their commitment to meeting global challenges and enhancing response to infectious diseases is evident through their ongoing clinical trials for COVID-19 therapies and their efforts to escalate malaria care to those in need worldwide. With a team dedicated to innovation and a focus on creating potentially lifesaving medicines, 60 Degrees Pharmaceuticals is making a significant impact in the field of infectious disease medicines and therapies.
Generated from the website